Approved indications (FDA):

• Local anesthesia of normal, intact skin before minor procedures such as IV insertion, venipuncture, or superficial dermatologic surgery.
• Anesthesia of female genital mucous membranes for superficial minor surgery (for example, removal of genital warts) and as pretreatment before injection of another local anesthetic.

Common clinical and off-label uses:

• Widely used before blood draws, IV lines, vaccination, and minor skin procedures in adults and children to reduce needle pain.
• Frequently applied before dermatologic and cosmetic procedures (for example, laser treatments, minor skin excisions, dermal fillers, or tattooing) to lessen discomfort, even when not specifically named in the label.
• Sometimes used before certain pediatric procedures (such as circumcision) or other painful interventions based on clinician judgment; evidence for some of these uses is mixed and dosing must be very cautious in young infants.

Efficacy expectations:

• On intact skin under an occlusive dressing, meaningful numbing typically begins after about 30–60 minutes, reaches maximum depth around 60–120 minutes, and can persist for 1–2 hours after removal.
• For genital mucous membranes, onset is faster (about 5–10 minutes) because absorption is quicker, but duration is shorter.
• Clinical trials show significant reductions in procedure-related pain compared with no anesthetic or placebo cream for venipuncture and minor skin surgery; it has similar overall effectiveness to other topical amide anesthetics when used correctly.
• Because it is a eutectic mixture designed to penetrate intact skin, it often provides more consistent dermal anesthesia than older single-agent creams but requires advance application time.

General administration:

• For topical use only on the skin or, in adults, on female genital mucous membranes; do not inject or swallow.
• Apply a thick, even layer without rubbing in, usually measured in grams; often covered with an occlusive dressing to improve penetration and prevent accidental contact.
• Keep away from eyes, inside the nose, and inside the ear; do not apply on open wounds unless specifically directed.

Typical dosing on intact skin (adults):

• Minor procedures (for example, IV line, venipuncture): about 2.5 g over 20–25 cm², applied at least 1 hour before the procedure.
• Larger dermal procedures: proportionally larger amounts may be used, but total dose, treated area, and application time are usually limited (commonly to a maximum of 60 g over 400 cm² for no more than about 3–4 hours).

Female genital mucous membranes (adults):

• For superficial minor surgery or pretreatment before injection, a thick layer of about 5–10 g is applied directly for 5–10 minutes, usually without occlusion, then removed immediately before the procedure.

Pediatric dosing (intact skin, approximate label-based maxima):

• 0 up to 3 months or <5 kg: up to 1 g over 10 cm² for up to 1 hour.
• 3–12 months and >5 kg: up to 2 g over 20 cm² for up to 4 hours.
• 1–6 years and >10 kg: up to 10 g over 100 cm² for up to 4 hours.
• 7–12 years and >20 kg: up to 20 g over 200 cm² for up to 4 hours.
• Do not exceed the child’s weight-based maximum dose, area, or time, and ensure close adult supervision to prevent ingestion or eye contact.

Special dosing instructions:

• Use the smallest amount and shortest application time that provide adequate anesthesia for the planned procedure.
• Avoid using simultaneously with large amounts of other local anesthetic products unless a clinician has calculated the total combined dose.
• Patients with high methemoglobinemia risk or significant heart, liver, or blood disease may require lower maximum doses or alternative approaches.

Missed or mistimed application:

• If the cream was not applied early enough before a scheduled procedure, do not double the amount or leave it on longer than directed; instead, contact the healthcare provider to adjust timing or anesthesia plans.

Overdose management:

• Applying too much, using it on very large or broken areas, or accidental swallowing (especially in children) can cause serious toxicity.
• In case of suspected overdose—symptoms such as severe drowsiness, confusion, seizures, very slow or irregular heartbeat, bluish skin, or collapse—remove any remaining cream and seek emergency medical care or contact a poison control center immediately.

Common side effects (usually mild and short-lived):

• Temporary skin changes where applied, such as redness, paleness or blanching, mild swelling, warmth, or coolness.
• Tingling, numbness, or a brief burning or itching sensation when the cream is first put on.
• These reactions typically appear during or soon after application and resolve within a few hours after the cream is removed.

Serious or rare adverse effects (need urgent medical attention):

• Signs of methemoglobinemia (a blood disorder), especially in infants: gray, blue, or very pale skin or lips; shortness of breath; fast heartbeat; unusual tiredness; headache or confusion.
• Severe allergic reactions: hives; swelling of the face, lips, tongue, or throat; trouble breathing; dizziness or fainting.
• Symptoms of systemic local-anesthetic toxicity, usually with overdose or large areas: ringing in the ears, blurred vision, unusual drowsiness or agitation, tremors, seizures, slow heart rate, very low blood pressure, or collapse.

Warnings and precautions:

• Infants, especially under 3 months of age, are more vulnerable to methemoglobinemia; doses, treated area, and contact time must be strictly limited, and premature infants or those on methemoglobin-inducing drugs generally should not receive this cream.
• Use with caution in people with glucose-6-phosphate dehydrogenase (G6PD) deficiency, congenital or idiopathic methemoglobinemia, severe anemia, serious heart disease, or significant liver impairment.
• Do not apply to broken, inflamed, or heavily diseased skin unless directed, and never in the eyes or inside the ear canal.
• Pregnancy: experience has not shown clear harm when used on small areas as directed; systemic exposure is low, but use should still be limited to what is necessary.
• Breastfeeding: minimal amounts reach the bloodstream; brief, localized use as directed is generally considered compatible, avoiding application directly to the breast or areas the infant could ingest.
• Elderly patients may be more sensitive to systemic effects if large amounts are used, especially with heart, liver, or kidney disease.

Relative safety compared with other options:

• When applied in recommended amounts to intact skin for the recommended time, serious systemic reactions are rare and overall safety is good.
• Risk increases with large treated areas, prolonged application, use on broken skin, or combination with other local anesthetic products.

Side-effect reporting and safety updates:

• Suspected adverse effects can be reported to the U.S. Food and Drug Administration (FDA) through its MedWatch program (online or by phone).
• Package inserts and FDA drug safety communications are the primary sources for updated warnings, contraindications, and dosing changes.

Drug and supplement interactions:

• Other local anesthetics (including injectable lidocaine or prilocaine, or similar topical products) can add to total exposure and increase risk of toxicity; combined doses should be calculated by a clinician.
• Medicines that can cause or worsen methemoglobinemia—such as some nitrates and nitrites, benzocaine and other topical anesthetics, dapsone, certain sulfonamides, nitrofurantoin, and phenazopyridine—may have additive effects and should be used with caution.
• Class III antiarrhythmics (for example, amiodarone, sotalol, dofetilide) may increase the risk of cardiac conduction disturbances when combined with high systemic levels of local anesthetics.
• Significant liver enzyme–inhibiting drugs or conditions that reduce liver blood flow could slow clearance if high doses are absorbed, though usual topical use rarely causes important systemic interactions.
• No meaningful interactions with food are expected, and alcohol intake does not materially affect its topical action, but co-use with alcohol does not mitigate overdose risk.

Conditions requiring extra caution or avoidance:

• Preterm neonates, and full-term infants under 12 months receiving methemoglobin-inducing drugs, due to elevated risk of methemoglobinemia.
• Patients with G6PD deficiency, congenital or idiopathic methemoglobinemia, or significant anemia.
• Severe hepatic impairment, serious cardiac conduction disorders, or advanced heart failure, where systemic toxicity would be less well tolerated.
• Extensive atopic dermatitis or damaged skin, which can markedly increase absorption; application to such areas should generally be avoided or carefully limited.
• Application near or in the eyes or inside the ear canal (risk of corneal injury or potential ototoxicity if it reaches the middle ear).

Monitoring needs:

• Young infants or patients with blood or enzyme disorders may need observation for cyanosis and other signs of methemoglobinemia during and after use, especially when larger doses are applied.
• Patients on class III antiarrhythmics or with significant heart disease may warrant closer clinical monitoring if large areas are treated.
• Routine blood tests or ECGs are not required for typical short, small-area applications but may be considered for repeated high-dose or prolonged uses in high-risk patients.

Q: How long does lidocaine and prilocaine cream take to start working and how long does it last?
A: On intact skin under a dressing it usually takes about 30–60 minutes to provide good numbing, with peak effect around 1–2 hours, and the area often stays numb for about 1–2 hours after the cream is wiped off.

Q: Can I use this cream on my child or baby?
A: Yes, it is used in children and even full-term newborns, but infants—especially under 3 months—have strict limits on dose, area, and time, so a pediatric clinician should give exact instructions and the child must be closely watched to prevent ingestion or eye contact.

Q: Is lidocaine and prilocaine safe during pregnancy and while breastfeeding?
A: When used occasionally on small skin areas as directed, absorption into the bloodstream is low and available data have not shown clear harm in pregnancy or breastfeeding, but it should be used only when needed and not applied directly to the nipple or areas a nursing infant might suck.

Q: Can I use it on broken or irritated skin or inside the mouth?
A: No, unless specifically instructed by a clinician, it should be applied only to intact skin (and, in adults, to female genital mucosa as directed), not to open wounds, rashes, inside the mouth, nose, or ear canal, because damaged or mucosal surfaces greatly increase absorption and the risk of side effects.

Q: What happens if too much cream is used or a child swallows some?
A: Using excessive amounts, covering very large areas, leaving it on too long, or accidental swallowing—especially in young children—can lead to serious problems such as seizures, irregular heartbeat, or a dangerous blood condition called methemoglobinemia, and any such situation should be treated as an emergency with immediate medical or poison-control contact.

Q: Do I still need another anesthetic injection if I use this cream?
A: For many needle sticks and minor superficial procedures the cream alone is sufficient, but for deeper or more extensive surgery it is often used to reduce the pain of the initial injection of another local anesthetic rather than to replace it entirely.

Storage:

• Store the cream at room temperature (about 68–77°F / 20–25°C), protected from excessive heat, moisture, and freezing.
• Keep the tube tightly closed and out of sight and reach of children and pets.
• Do not store it in the bathroom or near sinks where it may get damp or overheated.

Disposal:

• Do not flush leftover cream or empty tubes down the toilet or pour them into drains.
• Whenever possible, use a community medicine take-back program or pharmacy-based disposal service.
• If no take-back option is available, follow local guidance; in general, discard in household trash in a sealed container or bag so children and animals cannot get to it.